Alta-innovations news

NewsRss FeedAtom Feed

PsiOxus Therapeutics announces positive data in cancer-related cachexia clinical trial".

Description
Mid-Stage Clinical Study of wasting disease therapeutic MT-102 shows reversal of cancer related wasting.
Date:
13/11/2013

BioIndustry Association congratulates UK company PsiOxus Therapeutics on being named EuropaBio's Most Innovative European Biotech SME

Description
As part of a prestigious European Biotech Week event in Brussels today, PsiOxus Therapeutics has been revealed as the recipient of the EuropaBio Most Innovative European Biotech SME Award 2013.
Date:
11/10/2013
Displaying 1 to 10 of 54
Previous 1 2 3 4 5 Next